Cornea News and Research

RSS

Long-term use of reverse geometry lenses may induce inflammatory response

Continuous long-term overnight use of reverse geometry lenses results in a significantly increased presence of inflammatory mediators compared with wearing 30-night silicone-hydrogel contact lenses or wearing no lenses, show study results.

27 Jul 2012

Early-age cataract surgery increases central corneal thickness

When congenital cataract surgery is performed at an early age, central corneal thickness increases, show study results published in the British Journal of Ophthalmology.

25 Jul 2012

Otsuka, Acucela commence rebamipide ophthalmic suspension Phase 3 trial in dry eye syndrome

Acucela Inc., a clinical stage biotechnology company focused on developing new treatments for blinding eye diseases, and Otsuka Pharmaceutical Co., Ltd., today announced the initiation of a Phase 3 clinical trial to evaluate rebamipide ophthalmic suspension in patients with dry eye syndrome.

19 Jul 2012

Physicists develop new nanoscale materials using moth eyes

Using the compound eyes of the humble moth as their inspiration, an international team of physicists has developed new nanoscale materials that could someday reduce the radiation dosages received by patients getting X-rayed, while improving the resolution of the resulting images.

4 Jul 2012

FDA approves Abbott’s Healon EndoCoat OVD device

Abbott announced today that it has expanded its Healon family of ophthalmic viscosurgical devices (OVDs) with the U.S. Food and Drug Administration approval of Healon EndoCoat OVD, a device intended for use as a surgical aid in cataract extraction and intraocular lens (IOL) implantation.

4 Jul 2012

Glaukos receives FDA approval for iStent Trabecular Micro-Bypass Stent System

Today, the iStent Trabecular Micro-Bypass Stent System, Model GTS100R/L, was approved by the U.S. Food and Drug Administration. This is the first device approved for use in combination with cataract surgery to reduce pressure inside the eye (intraocular pressure) in adult patients with mild or moderate open-angle glaucoma and a cataract who are currently being treated with medication to reduce intraocular pressure.

26 Jun 2012

AIO first in the Pittsburgh area to offer laser surgery for cataract removal

Associates in Ophthalmology (AIO), an eye care and surgery practice with seven locations in the Tri-State Area, has become the region's first medical group to offer bladeless, computer-controlled laser surgery for cataract removal.

23 Jun 2012

FDA clears LensAR Laser System for anterior capsulotomy

LensAR Inc., developer of the LensAR Laser System for cataract surgery, announced today that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for the company's next-generation commercial system, for use in anterior capsulotomy, with and without laser phacofragmentation during cataract surgery.

18 Jun 2012

New method enhances adhesion of injected CECs for successful corneal transplantation

Regenerative medicine, or the use of specially grown tissues and cells to treat injuries and diseases, has been successful in treating disorders of a number of organs, including heart, pancreas, and cartilage. However, efforts to treat disorders of the corneal endothelium, a single cell layer on the inner surface of the cornea, with regenerative techniques have been less effective. Now, a group of scientists has developed a method that enhances the adhesion of injected corneal endothelial cells (CECs), allowing for successful corneal transplantation to repair pathological dysfunctions.

14 Jun 2012

Two video articles describe pre-surgical preparation of corneal tissue

Over 45,000 corneal transplant eye surgeries are performed in the US every year. On June 12, 2012, in an effort to standardize this complex procedure, two video articles describing pre-surgical preparation of corneal tissue were published in JoVE, the Journal of Visualized Experiments.

13 Jun 2012

VisionCare expands CentraSight telescope implant provider teams

VisionCare Ophthalmic Technologies, Inc., developer of the first FDA-approved ophthalmic telescope implant indicated to improve vision in patients with end-stage age-related macular degeneration (AMD), announced today the expansion of its CentraSight™ provider teams nationwide.

8 Jun 2012

Acne pills can cause eye infections

Millions of teenagers suffer from acne, and they deal with the embarrassing skin blemishes by taking popular prescription medications such as Accutane or Roaccutane. Now, however, research from Tel Aviv University shows that these pills can also cause eye infections such as conjunctivitis (pink eye) or sties.

24 May 2012

Cleveland Eye Clinic surgeons perform Corneal Cross-Linking procedure

For years, patients with an eye disease called keratoconus have had little to no hope of continuing to see well without glasses or contacts, and a portion of them had a high risk corneal transplant in their future. Keratoconus is an eye disease that causes the cornea (the clear covering on the eye) to become thin and steep over time. Patients with keratoconus can wear special contact lenses or in some cases glasses. Many of them lose the ability to see well even with corrective eye wear.

18 May 2012

Five-point checklist to protect eyes from sun’s harmful rays

Like your skin, overexposure to the sun can wreak havoc on your eyes. Sun damage can cause severe conditions such as sunburn to the cornea, tissue growth on the surface of eyes that can block vision, skin cancer of the eyelids and may even contribute to the development of cataracts and other eye problems.

14 May 2012

Bioactive formulation for optimal eye health

Morinda Bioactives (formerly Tahitian Noni International) recently announced the release of seven new Fit Body Composition Supplements, one of which is Fit Eye. Fit Eye provides an exclusive formulation of highly effective bioactives derived from the most potent sources, including research-recommended levels of lutein, to support optimal eye health.

8 May 2012

Repeating trinucleotide a strong predictor of Fuchs' dystrophy

Mayo Clinic and University of Oregon researchers have confirmed that a genetic factor called a repeating trinucleotide is a strong predictor of an individual's risk of developing the eye condition Fuchs' dystrophy. The findings were being presented today at the annual conference of the Association for Research in Vision and Ophthalmology in Orlando, Fla.

8 May 2012

Amniotic membrane transplantation prevents blindness in patients with SJS

Transplanting tissue from newborn fetal membranes prevents blindness in patients with a devastating disease called Stevens-Johnson syndrome, a Loyola University Medical Center study has found.

27 Apr 2012

Healthy emmetropic women have a wider pupil diameter than men

From an anatomical point of view, a normal, non-pathological eye is known as an emmetropic eye, and has been studied very little until now in comparison with myopic and hypermetropic eyes. The results show that healthy emmetropic women have a wider pupil diameter than men.

27 Apr 2012

FDA clears Abbott’s iFS Femtosecond laser for use in cataract surgery

Abbott announced today U.S. Food and Drug Administration clearance to use its iFS Advanced Femtosecond Laser to create bow-shaped or curved arcuate incisions in corneal surgery, including cataract surgery.

21 Apr 2012

OptiMedica's Catalys Precision Laser System receives CE mark approval

Global ophthalmic company OptiMedica Corp. has announced that its Catalys Precision Laser System has been CE mark approved for creating single-plane and multi-plane arc cuts/incisions in the cornea during cataract surgery.

12 Apr 2012